A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
NCT02297126
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
4465
Enrollment
OTHER
Sponsor class
Conditions
Adverse Drug Reaction
Interventions
OTHER:
Pharmacogenetic Intervention Arm (pharmacogenetic testing)
Sponsor
Indiana University
Collaborators
[object Object]